Peripheral Arterial Disease: Features

Sponsored Video

Real-World Evidence and Secondary Mechanism of Action of the Auryon Laser System

04/08/2024

A discussion with John Rundback, MD, and Bulent Arslan, MD

A discussion with John Rundback, MD, ...

Learn about the recently published safety and efficacy data of the Auryon Laser System.

Learn about the recently...

04/08/2024

Vascular Disease Management

ISET 2024

A Summary of Existing Data for the Use of 355nm Laser in BTK Arteries

03/18/2024

Timothy Yates, MD
CLI Vascular Specialists, West Palm Beach, Florida

Timothy Yates, MD CLI Vascular Specia...

Watch as Dr. Timothy Yates reviews his ISET 2024 presentation on the current data available for the use of a 355nm laser in below-the-knee arteries.

Watch as Dr. Timothy Yates...

03/18/2024

Vascular Disease Management

ISET 2024

Future Role of the Spur Stent: DEEPER LIMUS Trial Vessel Recoil Results

03/06/2024

Marianne Brodmann , MD;

Watch as Vascular Specialist Dr. Marianne Brodmann, from the Medical University of Graz in Austria, discusses her ISET 2024 presentation on the DEEPER LIMUS trial and how the Bare Temporary Spur Stent System can improve patient outcomes.

Watch as Vascular Specialist Dr....

03/06/2024

Vascular Disease Management

ISET 2024

Final Subgroup Analysis From the Rotarex Post-Market Study

03/06/2024

Michael Lichtenberg , MD, FESC;

Dr. Michael Lichtenberg discusses his presentation on the Rotarex Post-Market Study at ISET 2024.

Dr. Michael Lichtenberg...

03/06/2024

Vascular Disease Management

ISET 2024

LIFE-BTK: Is There a Difference Between RC4 and RC5 Patients?

03/06/2024

Ramon L. Varcoe , MBBS, MS, PhD;

In this video from ISET 2024, Ramon Varcoe, MBBS, MS, PhD, MMed (ClinEpi), discusses his presentation on the LIFE-BTK study.

In this video from ISET 2024,...

03/06/2024

Vascular Disease Management

ISET 2024

Natural Progress of High-Risk CLTI: The CLariTI Study 12-month Results

02/29/2024

Watch as Dr. Anahita Dua discusses her ISET 2024 presentation on the 12-month results of the CLariTI Study.

Watch as Dr. Anahita Dua...

02/29/2024

Vascular Disease Management

ISET 2024

Management of CLTI in an Era of BEST-CLI and BASIL-2

02/13/2024

Alik Farber , MD;

Dr. Alik Farber discusses his ISET 2024 presentation on the BEST-CLI and BASIL-2 trials and how to best manage patients with CLTI in the wake of these trials.

Dr. Alik Farber discusses his...

02/13/2024

Vascular Disease Management

Interview

One-Year Results From the LIFE-BTK Trial and 2-Year Results From the SWING Trial

02/07/2024

Ramon L. Varcoe , MBBS, MS, PhD;

VDM spoke with Ramon L. Varcoe, MBBS, MS, PhD, MMed (ClinEpi), about these 2 trials and what the current results mean for patients with PAD.

VDM spoke with Ramon L. Varcoe,...

02/07/2024

Vascular Disease Management

Interview

Advances in Deep Venous Arterialization and Coagulation Testing

01/19/2024

Anahita Dua , MD, MS, MBA, FACS;

Vascular Disease Management spoke with Dr. Anahita Dua to discuss her VEITH presentations on these topics as well as the research she is doing at Massachusetts General Hospital on coagulation testing.

Vascular Disease Management...

01/19/2024

Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

First Aid guidelines

AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies

11/14/2024

These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.

These are the first major...

11/14/2024

Cath Lab Digest

Late-Breaking Trials

Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/06/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...

The VIVA Foundation, a...

11/06/2024

Vascular Disease Management

Late-Breaking Trials

Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/05/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/05/2024

Vascular Disease Management

Late-Breaking Trials

Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Late-Breaking Trials

First Round of Late-Breaking Clinical Trial Results Announced at VIVA24

11/04/2024

The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...

The VIVA Foundation, a...

11/04/2024

Vascular Disease Management

Image-Guided Therapy

Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease

11/04/2024

With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...

With a unique world-first...

11/04/2024

Vascular Disease Management

Pulmonary Embolism

Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism

11/04/2024

QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...

QUADRA-PE study will evaluate...

11/04/2024

Vascular Disease Management

Peripheral Arterial Disease

FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease

11/04/2024

MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...

MOUNTAIN VIEW, Calif. – November...

11/04/2024

Vascular Disease Management

Patient Awareness

Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases

10/31/2024

New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...

New survey reveals nearly one in...

10/31/2024

Vascular Disease Management

DCB

SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery

10/30/2024

Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...

Data from the prospective,...

10/30/2024

Cath Lab Digest

Peripheral Arterial Disease: Features

Stay in the Know

News

Specialties

Events

Year Round Education

HMP Global Products